U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07565727) titled 'Cardiometabolic Disease and Substrate Metabolism' on April 27.
Brief Summary: This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and maternal lipid oxidation.
Study Start Date: Dec. 10, 2025
Study Type: OBSERVATIONAL
Condition:
Preeclampsia
Gestational Diabetes Mellitus (GDM)
Preeclampsia (PE)
Preeclampsia (PE) Risk
Gestational Diabetes
Gestational Diabetes Mellitus in Pregnancy
Cardiometabolic Diseases
Insulin Resistance
Placental Dysfunction
Pregnancy
Pregnancy Complications
Gestational Complications
Recruitment Status: RECRUITING
...